1. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age 
Mikkel Rosendahl, M.D., Claus Yding Andersen, D.M.Sc., Nina la Cour Freiesleben, M.D., Anders Juul, M.D., D.M.Sc., Kristine Løssl, M.D., Ph.D., Anders Nyboe Andersen, M.D., D.M.Sc. 
Fertility and Sterility 
Volume 94, Issue 1, Pages (June 2010)
DOI: /j.fertnstert
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
The time of visits in relation to chemotherapy and menstrual cycle.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Mean levels (± SEM) of markers of ovarian function during chemotherapy 1–8. (A) The day before and (B) 1 week after a treatment. Pyramids indicate 1 week after a series of chemotherapy.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
The development of levels of AMH and inhibin B after the first series of chemotherapy for patients who had an ovary removed between the two visits (n = 8) and patients with two ovaries (n = 9). Mean levels (± SEM).
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

5. Figure 4
Ovarian function during the recovery period after the end of chemotherapy. Mean levels (± SEM).
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions